Hahn RT, Lindenfeld J, Lim SD et al (2024) Structural Cardiac Interventions in Patients With Heart Failure. J Am Coll Cardiol 84:832–847. https://doi.org/10.1016/j.jacc.2024.05.061

Article  PubMed  Google Scholar 

Estep JD, Salah HM, Kapadia SR et al (2024) HFSA scientific statement: update on device based therapies in heart failure. J Card Fail 30:1472–1488. https://doi.org/10.1016/j.cardfail.2024.07.007

Article  PubMed  Google Scholar 

Nakata J, Yamamoto T, Saku K (2023) Mechanical circulatory support in cardiogenic shock. J Intensive Care 11:64. https://doi.org/10.1186/s40560-023-00710-2

Article  PubMed  PubMed Central  Google Scholar 

Mody R, Nee Sheth AB, Dash D et al (2024) Device therapies for heart failure with reduced ejection fraction: a new era. Front Cardiovasc Med 11:1388232. https://doi.org/10.3389/fcvm.2024.1388232

Article  PubMed  PubMed Central  CAS  Google Scholar 

Salah HM, Butler J, Fudim M (2023) Rapid sequence initiation of device therapy in heart failure. JACC Adv 2:100316. https://doi.org/10.1016/j.jacadv.2023.100316

Article  PubMed  PubMed Central  Google Scholar 

Chouairi F, Levin A, Fudim M (2024) Device therapy for heart failure management. Curr Opin Cardiol 39:465–474. https://doi.org/10.1097/HCO.0000000000001165

Article  PubMed  Google Scholar 

Chouairi F, Levin A, Biegus J, Fudim M (2024) Emerging devices for heart failure management. Prog Cardiovasc Dis 82:125–134. https://doi.org/10.1016/j.pcad.2024.01.011

Article  PubMed  Google Scholar 

Salah HM, Fudim M, Burkhoff D (2023) Device interventions for heart failure. JACC Heart Fail 11:1039–1054. https://doi.org/10.1016/j.jchf.2023.07.002

Article  PubMed  CAS  Google Scholar 

Rosenblum H, Kapur NK, Abraham WT et al (2020) Conceptual considerations for device-based therapy in acute decompensated heart failure: DRI2P2S. Circ Heart Fail 13:e006731. https://doi.org/10.1161/CIRCHEARTFAILURE.119.006731

Article  PubMed  Google Scholar 

Heidenreich PA, Bozkurt B, Aguilar D et al (2022) 2022 AHA/ACC/HFSA guideline for the management of heart failure. J Am Coll Cardiol 79:e263–e421. https://doi.org/10.1016/j.jacc.2021.12.012

Article  PubMed  Google Scholar 

Pipilas DC, Hanley A, Singh JP, Mela T (2023) Cardiac contractility modulation for heart failure: current and future directions. J Soc Cardiovasc Angiogr Interv 2:101176. https://doi.org/10.1016/j.jscai.2023.101176

Article  PubMed  PubMed Central  Google Scholar 

Zile MR, Lindenfeld J, Weaver FA (2020) Baroreflex activation therapy in patients with heart failure with reduced ejection fraction. J Am Coll Cardiol 76:1–13. https://doi.org/10.1016/j.jacc.2020.05.015

Article  PubMed  CAS  Google Scholar 

Vahanian A, Beyersdorf F, Praz F (2022) 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 43:561–632. https://doi.org/10.1093/eurheartj/ehab395

Article  PubMed  Google Scholar 

Bartko PE, Hülsmann M, Hung J et al (2020) Secondary valve regurgitation in patients with heart failure with preserved ejection fraction, heart failure with mid-range ejection fraction, and heart failure with reduced ejection fraction. Eur Heart J 41:2799–2810. https://doi.org/10.1093/eurheartj/ehaa129

Article  PubMed  PubMed Central  Google Scholar 

Stone GW, Lindenfeld J, Abraham WT et al (2018) Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 379:2307–2318. https://doi.org/10.1056/NEJMoa1806640

Article  PubMed  Google Scholar 

Bartko PE, Heitzinger G, Pavo N et al (2021) Burden, treatment use, and outcome of secondary mitral regurgitation across the spectrum of heart failure: observational cohort study. BMJ 373:n1421. https://doi.org/10.1136/bmj.n1421

Article  PubMed  PubMed Central  Google Scholar 

Adamo M, Tomasoni D, Stolz L et al (2023) Impact of transcatheter edge-to-edge mitral valve repair on guideline-directed medical therapy uptitration. JACC Cardiovasc Interv 16:896–905. https://doi.org/10.1016/j.jcin.2023.01.362

Article  PubMed  Google Scholar 

Fudim M, Spector AR, Costanzo M-R et al (2019) Phrenic nerve stimulation for the treatment of central sleep apnea: a pooled cohort analysis. J Clin Sleep Med 15:1747–1755. https://doi.org/10.5664/jcsm.8076

Article  PubMed  PubMed Central  Google Scholar 

Riley JM, Fradin JJ, Russ DH (2024) Post-capillary pulmonary hypertension: clinical review. J Clin Med 13:625. https://doi.org/10.3390/jcm13020625

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rosenkranz S, Gibbs JSR, Wachter R et al (2016) Left ventricular heart failure and pulmonary hypertension. Eur Heart J 37:942–954. https://doi.org/10.1093/eurheartj/ehv512

Article  PubMed  Google Scholar 

Caravita S, Baratto C, Filippo A et al (2023) Shedding light on latent pulmonary vascular disease in heart failure with preserved ejection fraction. JACC: Heart Failure 11:1427–1438. https://doi.org/10.1016/j.jchf.2023.03.003

Article  PubMed  CAS  Google Scholar 

Kadish A, Nademanee K, Volosin K (2011) A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. Am Heart J 161(2):e1-2. https://doi.org/10.1016/j.ahj.2010.10.025

Article  Google Scholar 

Abraham WT, Kuck K-H, Goldsmith RL et al (2018) A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation. JACC: Heart Failure 6:874–883. https://doi.org/10.1016/j.jchf.2018.04.010

Article  PubMed  Google Scholar 

Impulse Dynamics (2024) Assessment of implantable CCM in the heart failure group with higher ejection fraction. https://www.cms.gov/medicarecoverageideapproved-ide-studies/g200042-nct05064709

Impulse Dynamics (2024) Assessment of the safety and efficacy of a combined cardiac contractility modulation and implantable cardioverter defibrillator device for subjects with heart failure and reduced ejection fraction. https://clinicaltrials.gov/study/NCT05855135

Brener MI, Kapadia SR, Burkhoff D (2023) Reverse left ventricular remodeling with transcatheter interventions in chronic heart failure syndromes: an updated appraisal of the device landscape. J Soc Cardiovasc Angiogr Interv 2:101196. https://doi.org/10.1016/j.jscai.2023.101196

Article  PubMed  PubMed Central  Google Scholar 

Masarone D, Kittleson MM, D’Onofrio A et al (2024) Basic science of cardiac contractility modulation therapy: molecular and electrophysiological mechanisms. Heart Rhythm 21:82–88. https://doi.org/10.1016/j.hrthm.2023.09.021

Article  PubMed  Google Scholar 

Rao IV, Burkhoff D (2021) Cardiac contractility modulation for the treatment of moderate to severe HF. Expert Rev Med Devices 18:15–21. https://doi.org/10.1080/17434440.2020.1853525

Article  PubMed  CAS  Google Scholar 

Masarone D, Kittleson MM, De Vivo S et al (2022) Effects of cardiac contractility modulation electrodes on tricuspid regurgitation in patients with heart failure with reduced ejection fraction: a pilot study. J Clin Med 11:7442. https://doi.org/10.3390/jcm11247442

Article  PubMed  PubMed Central  Google Scholar 

Molina-Linde JM, Cordero-Pereda D, Baños-Álvarez E et al (2023) Efficacy and safety of baroreflex activation therapy for heart failure with reduced ejection fraction: systematic review. ESC Heart Fail 10:2760–2772. https://doi.org/10.1002/ehf2.14473

Article  PubMed  PubMed Central  Google Scholar 

Shi R, Sun T, Wang M et al (2024) Baroreflex activation therapy for heart failure with reduced ejection fraction: a comprehensive systematic review and meta-analysis. Heliyon 10:e24177. https://doi.org/10.1016/j.heliyon.2024.e24177

Article  PubMed  PubMed Central